Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

Inclusion Criteria: * Patients of Chinese ethnicity * Patients at least 2 years old * Signed informed consent from patient and if applicable from parent(s) or legal guardian(s) in compliance with local requirements * Patients with mild to moderate AD and depending on the age: * Patients 2-12 years must have: \- SCORAD Index \< 50 * Patients 13 years and older must have: * Affecting sensitive skin areas (e.g. face, intertriginous sites, anogenital area) * SCORAD Index \< 50 and IGA in sensitive skin areas ≤ 3 Exclusion Criteria: * Patients for whom Elidel® is not recommended accordingly to the Package Insert * Patients with severe atopic dermatitis (SCORAD Index ≥ 50 or IGA in sensitive skin \> 3) * Receiving systemic glucocorticoids, antibiotics, antifungals, immunomodulators, inhibitors, antihistamines and ultraviolet radiation therapy within the last 4 weeks before inclusion; * Receiving any topical AD-effective drugs within the last 2 weeks before inclusion; * Pregnant and/or breastfeeding women * Patients or parent(s) / legal guardian (as applicable) that are not able to fulfil study requirements according to physician's opinion * Patients or parent(s) / legal guardian (as applicable) that refuse to participate to the study